Middle of the road for CEOs: Bristol Myers' Giovanni Caforio secured almost $20M in 2021 compensation
Bristol Myers Squibb filed with the SEC recently, and now we know exactly how much the Big Pharma chief got in his paychecks last year.
Amid the company facing patent losses next year, especially for megablockbuster Revlimid, Giovanni Caforio ended up at a slight drop at $19.7 million, compared with his income of just over $20 million in 2020. However, Caforio is still up compared with his 2019 salary of $18.7 million.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.